Pharma Journalist 8769 posts 0 comments

Boehringer Ingelheim and LEO Pharma have entered an exclusive global license and transfer agreement to commercialize and further develop SPEVIGO (spesolimab), a monoclonal antibody…
Read More...

Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for its cystic fibrosis (CF) treatment ALYFTREK (deutivacaftor/tezacaftor/vanzacaftor), following a…
Read More...

Otsuka Pharmaceutical Co., Ltd. has signed an asset purchase agreement with Swedish biotech firm Cantargia AB to acquire global rights to CAN10, a promising antibody drug candidate…
Read More...

Acumen Pharmaceuticals has entered into a strategic collaboration and licensing agreement with Japan-based JCR Pharmaceuticals to co-develop a next-generation Alzheimer’s disease…
Read More...

Navamedic ASA has officially completed its acquisition of DNE Pharma’s business, marking a major milestone in the company’s strategic expansion into the addiction treatment market. The…
Read More...

Secarna Pharmaceuticals and Vect-Horus have launched a strategic research collaboration to develop RNA-targeted therapeutics capable of crossing the blood-brain barrier (BBB) for…
Read More...

Transcend Therapeutics, a clinical-stage biotech focused on neuropsychiatric treatments, announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy…
Read More...

Merck Animal Health, a division of Merck & Co., Inc., announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO QUANTUM (fluralaner for extended-release injectable…
Read More...

Merck, known as MSD outside the U.S. and Canada, announced that it will acquire Verona Pharma plc in a $10 billion deal, strengthening its presence in the respiratory disease space. The…
Read More...

Indian pharmaceutical major Lupin Limited and pan-European drugmaker Zentiva Group have signed a license and supply agreement to commercialize Lupin’s biosimilar Certolizumab Pegol…
Read More...